πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8748114

ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphom

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8747863

Vaccine for shigella

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8747823

Compositions and methods for treating a keratin based substrate

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741313

Polypeptide vaccine and vaccination strategy against mycobacterium

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741947

Biologically active macrolides, compositions, and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741869

Oligodeoxynucleotide and its use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741649

Methods for enhancing genome stability and telomere elongation in embryonic stem cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741309

Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735126

Disease control with tick phospholipase A2

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735407

Purine derivatives as A3 adenosine receptor-selective agonists

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735369

Compositions and methods for inhibiting expression of a gene from the Ebola virus

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735355

Methods of use of fragments of secreted frizzled related protein, sFRP

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8735082

Gene signature for predicting prognosis of patients with solid tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8734830

Manufacturing method and apparatus of ultrafine particles having uniform particle size dis

KOREA UNITED PHARM. INC. Β· Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8728526

Coacervate microparticles useful for the sustained release administration of therapeutic a

The United States of America, Represented by Secretary of Department of Health and Human Services, NIH Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8729053

Nuclear factor kappa B pathway inhibitor composition and use of same

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8728488

Methods of inducing an immune response in a host by administering flavivirus immunogens co

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION Β· Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8722046

Human monoclonal antibodies protective against bubonic plague

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8722653

Method for treating uterine fibroids

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8722063

Vaccination of animals to elicit a protective immune response against tick infestations an

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8716301

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8716460

Pseudomonas AVR and HOP proteins, their encoding nucleic acids, and use thereof

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8716315

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8715751

Artemisinins in the clinical and veterinary management of kinetoplastid infections

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted